---
title: "Tirzepatide vs Semglutide: What is the difference? Can They Both Be Used with HRT?"
description: "Early evidence suggests GLP-1 medications can be used alongside menopausal hormone therapy in appropriately selected women, though menopause-specific research remains limited. Protecting muscle, bone, sleep, and long-term metabolic health is an important part of treatment planning during midlife."
url: "https://www.myalloy.com/blog/tirzepatide-vs-semglutide-what-is-the-difference"
---

# Tirzepatide vs Semglutide:  What is the difference?  Can They Both Be Used with HRT? 

*How GLP-1 medications may affect weight, muscle, metabolism, and hormone therapy during midlife*

By Cheyenne Buckingham

## Summary

For women in perimenopause or menopause, **tirzepatide vs. semaglutide** differs mainly in how the medications work: semaglutide targets GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP receptors and may produce greater average weight loss. Both can often be used with **hormone replacement therapy (HRT)**, although slowed stomach emptying may affect oral estradiol absorption; treatment decisions should also consider side effects, medical history, muscle preservation, and bone health.

[Start Your Weight Care Consult](https://secure.myalloy.com/experience?categories%5B%5D=weight-health&sku-ids%5B%5D=6f32bad4-76bd-4b07-8bbd-233c298bb222%2C32f106c4-4054-4f19-a774-dfe9afc12190&skip-category-select=true&type=intake)

If you’ve entered perimenopause and suddenly feel like your usual meal prep and exercise routine aren’t working the way they used to, you’re not imagining things. Hormonal fluctuations during this life stage can make managing your weight feel like an uphill battle.

This is where [GLP-1 medications](https://www.myalloy.com/blog/how-do-glp-1s-work) can help. [Semaglutide](https://www.myalloy.com/blog/what-is-compounded-semaglutide-and-how-long-before-it-works) and [tirzepatide](https://www.myalloy.com/solutions/compounded-tirzepatide) have changed the landscape of weight management. Both can lead to significant weight loss, but they work a little differently. You may also be wondering whether you can take either medication alongside hormone replacement therapy (HRT).

Here’s what to know about each medication, including whether they pair well with hormone replacement therapy. Plus, learn tips for maintaining muscle mass while taking one of these weight loss medications.

## Why Does Weight Management Get Harder During Menopause?

[Weight gain](https://www.myalloy.com/blog/why-do-women-gain-weight-during-menopause) is common during perimenopause and after menopause, especially around your midsection. That’s largely because estrogen plays a role in where your body stores fat. During your reproductive years, you may notice more fat around your hips, butt, and thighs. But as estrogen levels decline, you may start storing more fat around your abdomen, including [visceral fat](https://www.myalloy.com/blog/why-visceral-fat-targets-your-heart-after-menopause), which surrounds your internal organs. This shift in fat storage is often referred to colloquially as [menopause (or meno) belly](https://www.myalloy.com/blog/what-is-menopause-belly-why-do-i-feel-so-bloated).

Meanwhile, age-related muscle loss can slow your metabolism. Because muscle is denser than fat, you may notice changes in your body composition without much movement on the scale. If [hot flashes and night sweats](https://www.myalloy.com/blog/dealing-with-hot-flashes-and-night-sweats) are sabotaging your sleep, that can make managing your weight even more challenging. Throw in everyday stress and fatigue from work or family responsibilities, and maintaining your usual weight may require way more effort.

## How Semaglutide and Tirzepatide Work

Both medications help curb hunger and food cravings, increase feelings of fullness, slow stomach emptying, and regulate blood sugar. But there’s one important distinction in how they work.

[Semaglutide](https://www.myalloy.com/solutions/compounded-semaglutide), the active ingredient in [Wegovy](https://www.myalloy.com/solutions/wegovy) and Ozempic, mimics a hormone called glucagon-like peptide-1 (GLP-1), which helps signal fullness to your brain and regulate insulin secretion.

**Compounded Semaglutide**

Plus $99/month Alloy Weight Care

Weekly injection. Personalized dosing for gentler starts and individual goals**


[Start Now](https://secure.myalloy.com/experience?categories%5B%5D=weight-health&sku-ids%5B%5D=6f32bad4-76bd-4b07-8bbd-233c298bb222%2C32f106c4-4054-4f19-a774-dfe9afc12190%2Cfab5fef8-7a28-44f2-8385-f65c7d18e739&skip-category-select=true&skip-treatment-select=true&type=intake)

Tirzepatide, the active ingredient in [Zepbound](https://www.myalloy.com/solutions/zepbound) and Mounjaro, activates GLP-1 receptors as well as receptors for another hormone called glucose-dependent insulinotropic polypeptide (GIP). In other words, tirzepatide works through two hormonal pathways instead of one.

### Does Tirzepatide lead to more weight loss?

Research suggests it can. In the [2025 SURMOUNT-5 clinical trial](https://pubmed.ncbi.nlm.nih.gov/40353578/), which followed 751 adults with obesity (but without diabetes) for 72 weeks, **participants taking tirzepatide lost an average of 20.2% of their body weight, compared with 13.7% among those taking semaglutide.**

Of course, that weight loss doesn’t happen overnight. While you may notice changes in your appetite relatively quickly, meaningful weight loss typically unfolds over several months, alongside other healthy habits such as diet and exercise.

Of course, your starting weight, metabolic health, diet, physical activity, and how well you tolerate the medication can all influence how you respond. It’s also worth remembering that this study wasn’t designed specifically for women going through menopause, so more research is needed to understand how the medications compare during this life stage.

[Watch video](https://www.youtube.com/watch?v=PQ60VjfnliA)

That being said, we know menopause can impact metabolism. Even women who haven’t struggled with their weight before may suddenly find that their usual diet and exercise routines just aren’t working. This is where medications like semaglutide and tirzepatide can be especially helpful. They can give an extra boost with weight loss while also improving metabolic health and reducing certain long-term health risks. While these medications don’t directly treat menopause symptoms, they can be a great tool for women who meet the criteria for treatment and are struggling with weight changes during this transition.

## What About Muscle Loss and Bone Health?

Seeing the number on the scale go down can be incredibly exciting. But, it’s important to pay attention to what *kind *of weight you’re losing: fat versus lean body mass. 

But losing lean mass doesn’t automatically mean you’re losing muscle strength. In fact, a [2026 review](https://pubmed.ncbi.nlm.nih.gov/42772087/) that looked at postmenopausal women using semaglutide emphasized that reductions in lean body mass don’t necessarily translate to meaningful muscle loss or impaired physical function.

Still, preserving muscle should be part of your [weight-loss plan](https://www.myalloy.com/blog/menopause-protective-protocol-for-glp-1-weight-loss). Resistance training is one of the best ways to maintain strength, and eating enough protein and total calories matters, too, especially if your medication is making you feel full after just a few bites. In addition to moderate exercise, the American Board of Obesity Medicine (ABOM) recommends two days of strength training per week. Building muscle also helps to boost metabolism 

[Bone health](https://www.myalloy.com/blog/protecting-your-bone-health-why-semaglutide-and-menopause-care-belong-together) is another consideration. A [2026 position statement](https://pubmed.ncbi.nlm.nih.gov/42664617/) from the Spanish Menopause Society recommends factoring in fracture risk and skeletal health when prescribing GLP-1 medications to women during and after menopause. This is another reason why strength training is so important during menopause and when taking weight-loss medications. 

Your clinician may recommend monitoring your bone health based on your age, medical history, and individual risk factors as you take weight loss medications.

## Can You Take Semaglutide or Tirzepatide With HRT?

The short answer? Yes, many women can safely take [GLP-1 medications alongside hormone replacement therapy (HRT)](https://www.myalloy.com/blog/why-glp-1s-and-hrt-are-a-beneficial-combination).

And there's some early research suggesting the combination may offer an added weight-loss benefit. One [2024 study](https://pmc.ncbi.nlm.nih.gov/articles/PMC11209769/) found that postmenopausal women taking semaglutide alongside HRT lost more weight than those taking semaglutide alone. However, the study was observational, so we can’t necessarily say for sure that HRT was responsible for this difference.

Of course, HRT isn’t a weight-loss medication, but it may play an indirect positive role in your weight loss protocol. Its main job is to relieve [menopause symptoms](https://www.myalloy.com/symptoms) like hot flashes, disrupted sleep, and changes in vaginal health. When you feel more like yourself, it’s easier to stick to healthy habits, right?

One thing to keep in mind if you take oral estrogen: GLP-1 medications slow stomach emptying, which could potentially affect how certain oral medications are absorbed (estradiol included). A [2025 case report](https://www.ovid.com/jnls/menopausejournal/abstract/10.1097/gme.0000000000002621~worsening-vasomotor-symptoms-in-the-setting-of-estradiol-and?redirectionsource=fulltextview) raised this possibility with semaglutide and oral estradiol, although more research is needed.

If you’re considering both treatments, talk with your clinician about which HRT formulation makes the most sense for you. Estradiol patches, gels and sprays, for example, deliver estrogen through your skin, bypassing your digestive tract altogether.

**Estradiol Patch**

Apply it once or twice a week and estrogen is absorbed steadily through your skin. 


## What Side Effects Should You Consider?

Like most medications, semaglutide and tirzepatide come with potential [side effects](https://www.myalloy.com/blog/are-glp-1-medications-safe-and-what-about-side-effects), with nausea, constipation, diarrhea, heartburn, and stomach discomfort among the most common.

These symptoms often improve as your body adjusts, but they can be particularly unwelcome if menopause has already left you exhausted or [struggling to sleep](https://www.myalloy.com/symptoms/trouble-with-sleep).

Eating smaller meals, staying hydrated, and slowly increasing your dose under your clinician’s guidance can help make treatment more tolerable.

But GLP-1 medications aren’t for everyone. You shouldn't take either medication if you or someone in your family has a history of medullary thyroid cancer or if you have multiple endocrine neoplasia syndrome type 2 (MEN2). That’s because both medications have been linked to thyroid tumors in [animal studies](https://academic.oup.com/endo/article-abstract/151/4/1473/2456651?redirectedFrom=fulltext), although it's unclear whether they pose the same risk in humans. 

A history of pancreatitis or severe digestive problems also deserves a conversation with your clinician. 

## Which Medication Makes More Sense During Menopause?

If losing more weight is your main priority, tirzepatide may have the leg up. But according to that [2026 position statement](https://pubmed.ncbi.nlm.nih.gov/42664617/) from the Spanish Menopause Society, there’s currently more research behind semaglutide supporting weight loss and management during the menopausal transition. Even so, that evidence is still considered limited.

One is not automatically better than the other. Your medical history, metabolic health, weight-loss goals, and how well you tolerate side effects all deserve a seat at the table when deciding which medication to try.

Most importantly, neither medication is a substitute for healthy habits. Eating enough protein, lifting weights, and getting quality sleep are still important, especially when you’re trying to preserve muscle during menopause.

[Start Now](https://secure.myalloy.com/experience?categories%5B%5D=weight-health&sku-ids%5B%5D=6f32bad4-76bd-4b07-8bbd-233c298bb222%2C32f106c4-4054-4f19-a774-dfe9afc12190&skip-category-select=true&type=intake)

---

## 
Frequently Asked Questions


### How do semaglutide and tirzepatide differ?

Semaglutide mimics glucagon-like peptide-1 (GLP-1) to signal fullness to the brain and regulate insulin secretion. Tirzepatide targets two hormonal pathways instead of one by activating both GLP-1 receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors, which clinical research suggests may result in greater average weight loss.

### Can you take GLP-1 medications alongside hormone replacement therapy?

Many women can safely use GLP-1 medications alongside hormone replacement therapy, and early research suggests the combination may offer an added weight loss benefit. Because GLP-1 medications slow stomach emptying and could potentially alter the absorption of oral estradiol, non-oral HRT options such as patches, gels, or sprays that bypass the digestive tract are often considered.

### How do you protect muscle mass and bone health during menopausal weight loss?

Preserving muscle strength and skeletal health requires consistent resistance training combined with adequate daily protein and calorie intake. Incorporating strength training at least two days per week helps counteract age-related metabolic slowdown, maintains physical function, and addresses potential fracture risks while taking weight loss medications.

## Related Content

1. [https://www.myalloy.com/blog/protecting-your-bone-health-why-semaglutide-and-menopause-care-belong-together](https://www.myalloy.com/blog/protecting-your-bone-health-why-semaglutide-and-menopause-care-belong-together)
2. [https://www.myalloy.com/blog/semaglutide-alternatives-that-support-weight-loss-during-menopause](https://www.myalloy.com/blog/semaglutide-alternatives-that-support-weight-loss-during-menopause)
3. [https://www.myalloy.com/blog/why-glp-1s-and-hrt-are-a-beneficial-combination](https://www.myalloy.com/blog/why-glp-1s-and-hrt-are-a-beneficial-combination)
4. [https://www.myalloy.com/blog/are-glp-1-medications-safe-and-what-about-side-effects](https://www.myalloy.com/blog/are-glp-1-medications-safe-and-what-about-side-effects)
5. [https://www.myalloy.com/blog/menopause-protective-protocol-for-glp-1-weight-loss](https://www.myalloy.com/blog/menopause-protective-protocol-for-glp-1-weight-loss)
6. [https://www.myalloy.com/blog/oral-vs-injectable-tirzepatide-for-menopause-weight-loss](https://www.myalloy.com/blog/oral-vs-injectable-tirzepatide-for-menopause-weight-loss)
7. [https://www.myalloy.com/blog/what-is-compounded-semaglutide-and-how-long-before-it-works](https://www.myalloy.com/blog/what-is-compounded-semaglutide-and-how-long-before-it-works)
8. [https://www.myalloy.com/blog/why-do-women-gain-weight-during-menopause](https://www.myalloy.com/blog/why-do-women-gain-weight-during-menopause)
9. [https://myalloy.zendesk.com/hc/en-us/articles/39471023349523-Can-I-take-GLP-1-medication-with-Menopausal-Hormone-Therapy-HRT](https://myalloy.zendesk.com/hc/en-us/articles/39471023349523-Can-I-take-GLP-1-medication-with-Menopausal-Hormone-Therapy-HRT)

## Citations

1. Manuel Sánchez-Prieto, Marina Romero-Domínguez, Rodrigo Orozco, Mariella Lilue, Daniel María Lubián-López, Silvia P González, et al.. Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society. Maturitas 2026;213:109101. doi:10.1016/j.maturitas.2026.109101. PMID:42664617. — [View source](https://linkinghub.elsevier.com/retrieve/pii/S0378-5122%2826%2900278-1)
2. Maria D Hurtado, Elif Tama, Sima Fansa, Wissam Ghusn, Diego Anazco, Andres Acosta, et al.. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause 2024;31(4):266-274. PMID:38446869. — [View source](https://pmc.ncbi.nlm.nih.gov/articles/pmid/38446869/)
3. Santiago Palacios, Peter Chedraui, Rafael Sanchez-Borrego, Pluvio Coronado, Tommaso Simoncini, Katrin Schauding, et al.. Management of obesity in menopause. Climacteric 2024;27(4):357-363. PMID:39016333. — [View source](https://www.tandfonline.com/doi/10.1080/13697137.2024.2374760?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed)
4. Nadia Raci Marques Pereira, Isabela Antunes Ishikura, Sergio Tufik, Helena Hachul. Semaglutide in postmenopausal women: Clinical implications for weight loss, muscle health, and sleep-disordered breathing. Maturitas 2026;214:109129. doi:10.1016/j.maturitas.2026.109129. PMID:42772087. — [View source](https://linkinghub.elsevier.com/retrieve/pii/S0378-5122%2826%2900306-3)
5. Stavroula A Paschou, Ljiljana V Marina, Eleftherios Spartalis, Panagiotis Anagnostis, Andreas Alexandrou, Dimitrios G Goulis, et al.. Therapeutic strategies for type 2 diabetes mellitus in women after menopause. Maturitas 2019;126:69-72. doi:10.1016/j.maturitas.2019.05.003. PMID:31239121. — [View source](https://linkinghub.elsevier.com/retrieve/pii/S0378-5122%2819%2930128-8)
6. Erin S LeBlanc, Neon Brooks, Melinda Davies, Ranee Chatterjee. Sex-Specific Cardiovascular Risk Factors and Treatment in Females With T2DM and CVD: Developments and Knowledge Gaps. J Clin Endocrinol Metab 2024;109(12):e2167-e2177. PMID:39312230. — [View source](https://academic.oup.com/jcem/article-lookup/doi/10.1210/clinem/dgae655)
7. Anna E Parker. Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report. Menopause 2025;32(12):1168-1170. doi:10.1097/GME.0000000000002621. PMID:40729307. — [View source](https://www.ovid.com/10.1097/GME.0000000000002621)
8. Jose A Santos-Marcos, Oriol A Rangel-Zuñiga, Rosa Jimenez-Lucena, Gracia M Quintana-Navarro, Sonia Garcia-Carpintero, Maria M Malagon, et al.. Influence of gender and menopausal status on gut microbiota. Maturitas 2018;116:43-53. PMID:30244778. — [View source](https://linkinghub.elsevier.com/retrieve/pii/S0378-5122%2818%2930263-9)

---

*This is a markdown version of [https://www.myalloy.com/blog/tirzepatide-vs-semglutide-what-is-the-difference](https://www.myalloy.com/blog/tirzepatide-vs-semglutide-what-is-the-difference) for AI/LLM consumption.*